Table 2.
Counts of EMT phenotypic CTCs in CTCs positive patients
| Patients | Gender | Age | CTCs count (n) | E+CTCs count (n) | E+/M+CTCs count (n) | M+CTCs count (n) |
|---|---|---|---|---|---|---|
| 1 | M | 66 | 2 | 1 | 1 | 0 |
| 2 | M | 62 | 2 | 2 | 0 | 0 |
| 3 | M | 57 | 2 | 1 | 1 | 0 |
| 4 | M | 80 | 2 | 2 | 0 | 0 |
| 5 | M | 50 | 2 | 1 | 1 | 0 |
| 6 | F | 64 | 2 | 1 | 0 | 1 |
| 7 | M | 68 | 2 | 0 | 0 | 2 |
| 8 | F | 48 | 3 | 1 | 2 | 0 |
| 9 | M | 51 | 3 | 2 | 1 | 0 |
| 10 | M | 50 | 3 | 1 | 1 | 1 |
| 11 | M | 82 | 3 | 0 | 2 | 1 |
| 12 | M | 68 | 4 | 1 | 2 | 1 |
| 13 | M | 44 | 4 | 1 | 1 | 2 |
| 14 | M | 71 | 4 | 2 | 1 | 1 |
| 15 | M | 62 | 4 | 1 | 2 | 1 |
| 16 | F | 67 | 4 | 2 | 1 | 1 |
| 17 | M | 60 | 4 | 1 | 1 | 2 |
| 18 | M | 68 | 5 | 2 | 1 | 2 |
| 19 | F | 64 | 6 | 3 | 1 | 2 |
| 20 | M | 61 | 6 | 2 | 3 | 1 |
| 21 | F | 62 | 6 | 2 | 2 | 2 |
| 22 | M | 60 | 6 | 1 | 3 | 2 |
| 23 | M | 69 | 7 | 2 | 2 | 3 |
| 24 | M | 64 | 8 | 4 | 2 | 2 |
| 25 | F | 62 | 8 | 3 | 3 | 2 |
| 26 | M | 62 | 9 | 4 | 2 | 3 |
| 27 | M | 70 | 12 | 3 | 5 | 4 |
| 28 | M | 65 | 12 | 4 | 5 | 3 |
| 29 | M | 65 | 13 | 6 | 4 | 3 |
Abbreviations: CTCs, circulating tumor cells; E+/M+CTCs, biophenotypic CTCs; E+CTCs, epithelial CTCs; EMT, epithelial‐mesenchymal transition; F, female; M, male; M+CTCs, mesenchymal CTCs.